Steris (STE) Free Cash Flow Growth (1y) (2019 - 2026)
Steris (STE) Free Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -14.34% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 19.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.34% |
| Mar 31, 2026 | 29.12% |
| Dec 31, 2025 | -18.10% |
| Sep 30, 2025 | 35.19% |
| Jun 30, 2025 | 66.87% |
| Mar 31, 2025 | 16.24% |
| Dec 31, 2024 | 41.38% |
| Sep 30, 2024 | 137.09% |
| Jun 30, 2024 | -8.82% |
| Mar 31, 2024 | 13.17% |
| Dec 31, 2023 | 51.47% |
| Sep 30, 2023 | 198.27% |
| Jun 30, 2023 | 85.24% |
| Mar 31, 2023 | 46.31% |
| Dec 31, 2022 | -30.29% |
| Sep 30, 2022 | -77.69% |
| Jun 30, 2022 | 182.26% |
| Mar 31, 2022 | -12.76% |
| Dec 31, 2021 | 7.39% |
| Sep 30, 2021 | -20.07% |